New hope for rare heart condition: AGP100 trial aims to tame dangerous rhythms
Disease control
Recruiting now
This study tests a new drug, AGP100, in 10 adults with a rare inherited heart condition called CPVT, which can cause dangerously fast heartbeats during exercise or stress. Participants take three different doses of AGP100 alongside their usual medication over six weeks, with hosp…
Phase: PHASE2 • Sponsor: Agiana Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:46 UTC